Skip to Main Content

Paper Details

Lutetium-177 PSMA for the treatment of metastatic castrate resistant prostate cancer: a systematic review.
Expert Rev Anticancer Ther
7
2023
Author NameAffiliation
Daniel E SprattUniversity Hospitals Seidman Cancer Center
Daniel E SprattCase Comprehensive Cancer Center
  • 1 - 2

Datasets

Release 1.2